BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25494197)

  • 1. Asymmetric papilledema in idiopathic intracranial hypertension.
    Bidot S; Bruce BB; Saindane AM; Newman NJ; Biousse V
    J Neuroophthalmol; 2015 Mar; 35(1):31-6. PubMed ID: 25494197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension.
    Bidot S; Clough L; Saindane AM; Newman NJ; Biousse V; Bruce BB
    J Neuroophthalmol; 2016 Jun; 36(2):120-5. PubMed ID: 26580295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema.
    Farrokhi Y; Sharif Kashani S; Aghsaei Fard M; Pakdel F; Yadegari S
    Clin Neurol Neurosurg; 2019 Sep; 184():105376. PubMed ID: 31176474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology of Papilledema in Patients in the Eye Clinic Setting.
    Crum OM; Kilgore KP; Sharma R; Lee MS; Spiegel MR; McClelland CM; Bhatti MT; Chen JJ
    JAMA Netw Open; 2020 Jun; 3(6):e206625. PubMed ID: 32484553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undiagnosed papilledema in a morbidly obese patient population: a prospective study.
    Krispel CM; Keltner JL; Smith W; Chu DG; Ali MR
    J Neuroophthalmol; 2011 Dec; 31(4):310-5. PubMed ID: 21799447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.
    Gospe SM; Bhatti MT; El-Dairi MA
    Br J Ophthalmol; 2016 Apr; 100(4):505-9. PubMed ID: 26269534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant optic disk drusen and papilledema due to idiopathic intracranial hypertension in a pediatric cohort.
    Tavakoli M; Yan F; Tauscher R
    J AAPOS; 2024 Feb; 28(1):103806. PubMed ID: 38216114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic Nerve Angle in Idiopathic Intracranial Hypertension.
    Chen BS; Asnafi S; Lin MY; Bruce BB; Lock JH; Sharma RA; Newman NJ; Biousse V; Saindane AM
    J Neuroophthalmol; 2021 Dec; 41(4):e464-e469. PubMed ID: 34788243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser scanning tomography measurement of the extent of papilledema in the follow-up examination of patients with idiopathic intracranial hypertension.
    Heckmann JG; Faschingbauer F; Lang C; Reulbach U; Dütsch M; Mardin CY; Schwab S
    J Neurosurg; 2007 Sep; 107(3):543-7. PubMed ID: 17886553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology, pathogenesis and management of idiopathic intracranial hypertension, and role of optic canal size in asymmetric papilledema: A review.
    Mitchell C; Mathew S; Harris A; Lang M; Mackay D; Kovoor J
    Eur J Ophthalmol; 2021 May; 31(3):892-903. PubMed ID: 33779328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Intracranial Pressure Monitoring for Diagnosis of Idiopathic Intracranial Hypertension in the Absence of Papilledema.
    Bridges KJ; Raslan AM
    World Neurosurg; 2018 Mar; 111():e221-e227. PubMed ID: 29258930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension.
    Padhye LV; Van Stavern GP; Sharma A; Viets R; Huecker JB; Gordon MO
    J Neurol Sci; 2013 Sep; 332(1-2):80-5. PubMed ID: 23850064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of presentation and course of idiopathic intracranial hypertension--a large cohort comprehensive study.
    Pollak L; Zohar E; Glovinsky Y; Huna-Baron R
    Acta Neurol Scand; 2013 Jun; 127(6):406-12. PubMed ID: 23278763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
    Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
    Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
    Dinkin MJ; Patsalides A
    J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal Manifestations of Idiopathic Intracranial Hypertension.
    Nichani P; Micieli JA
    Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between idiopathic intracranial hypertension and obesity.
    Hannerz J; Ericson K
    Headache; 2009 Feb; 49(2):178-84. PubMed ID: 19222591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral Papilledema in Idiopathic Intracranial Hypertension: A Case Series.
    Swinkin E; Jabehdar Maralani P; Sundaram AN
    Can J Neurol Sci; 2022 Mar; 49(2):278-281. PubMed ID: 33888167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of Idiopathic Intracranial Hypertension in Patients Over 50 Years of Age: A multicenter clinical cohort study.
    Downie PA; Chen JJ; Bhatti MT; Melson AT; Van Stavern GP; McClelland CM; Lindgren BR; Sharieff JA; Lee MS
    Am J Ophthalmol; 2021 Apr; 224():96-101. PubMed ID: 33253662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intracranial pressure in spontaneous CSF leak patients is not associated with papilledema.
    Aaron G; Doyle J; Vaphiades MS; Riley KO; Woodworth BA
    Otolaryngol Head Neck Surg; 2014 Dec; 151(6):1061-6. PubMed ID: 25248848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.